Evidence map›Paper›PMID 35125906›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2022

Cross-sectional study to evaluate burnout among pharmacy staff in Saudi Arabia during COVID-19 pandemic.

Lobna A Aljuffali, Munerah O Alshabanah, Haya M Almalag

Abstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lobna A AljuffaliDepartment of Clinical Pharmacy, King Saud University, College of Pharmacy, Riyadh, Saudi Arabia.
Munerah O AlshabanahKing Saud University, College of Pharmacy, Riyadh, Saudi Arabia.
Haya M AlmalagDepartment of Clinical Pharmacy, King Saud University, College of Pharmacy, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) has placed healthcare workers, including pharmacists, at an increased risk of infection and has increased their workload, which could lead to burnout. Therefore, the present study aimed to measure the levels of burnout among hospital and community pharmacists in Saudi Arabia during the COVID-19 pandemic and to identify the risk factors associated with burnout.

methodsIn the present cross-sectional study, an online survey was distributed among community and hospital (inpatient, outpatient, clinical, and administration) pharmacists in Saudi Arabia. The Copenhagen Burnout Inventory (CBI) survey was used to measure burnout levels. This 19-item survey covered three aspects: personal, work, and patient-related burnout. The survey included questions about socio-demographic factors and the major causes of psychological distress among pharmacists during the COVID-19 pandemic. Inferential statistics were used for data analysis.

resultsA total of 502 pharmacists were included in the present study. Of these, 59.1% were categorized as having clinically relevant burnout levels (scores ≥ 50).Univariate analysis revealed that the burnout level was significantly higher (p < 0.05) among pharmacists who were younger, were females, had lesser years of experience, or worked in the community pharmacy. The main factors associated with high burnout levels among community pharmacists were younger age, lesser years of experience, male gender, non-Saudi nationality, and higher numbers of customers. In the COVID-19 part of the survey, burnout was found to be strongly related to the COVID-19 pandemic. Fears of getting infected or of a family member getting infected, fears of the pandemic lasting for too long, and increased working hours were factors contributing to increased burnout levels during the COVID-19 pandemic with unadjusted β of 8.336 and (95% CI 7.082-9.589, p value < 0.001). A lack of supportive work culture and sleeping disturbances were also found to be related to high burnout levels (p < 0.001).

conclusionsPharmacy staff in Saudi Arabia were found to experience high levels of burnout. The major risk factors causing burnout included younger age, female gender, lesser years of experience, a lack of supportive work culture, sleep disturbances, worries associated with increased workload during the pandemic, fears of getting infected, and increased working hours.

Indexed as

BurnoutCaregiversCOVID-19PandemicsPharmacistsProfessional

Identifiers

PMID35125906
PMCPMC8801617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.